Ignite Creation Date:
2024-07-17 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06487286
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-06-27
Brief Title:
Levels of VisfatinNAMPT in Human Milk
Sponsor:
Paolo Manzoni Study Group
Organization:
Paolo Manzoni
Study Overview
Official Title:
Levels of VisfatinNAMPT in Human MilkVISFAMILK
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VISFAMILK
Brief Summary:
Visfatin released in maternal milk at different concentrations related to the maternal conditions could act as a biomarker with a prognosticpredictive value to determine different newborn clinical conditions particularly the weight loss of the neonate
Detailed Description:
The aim of the study is to analyse a retrospective cohort of well characterized mothers in their post-partum period and to measure Visfatin levels through collection of maternal milk samples They will be collected in three different moments after the birth 48 hours 7 days and 30 days and Visfatin levels will be analysed through an ELISA kit Adipogen In parallel the levels of Visfatin will be evaluated in the maternal plasmaserum collected after 1-2 days postpartum
Lastly correlations between Visfatin levels and biologicalclinical features of mothers and newborns will be explored
Lastly correlations between Visfatin levels and biologicalclinical features of mothers and newborns will be explored
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None